Elise Frisch’s Post

Early execution of pre-clinical #toxicology provides confidence to investors, and can be pivotal to securing the next investment round. In standard DNA-to-IND offerings, toxicology animal testing needs to be completed within four to five months, including data analysis and generating a report. Lonza deploys advanced strategies and technologies to meet the deadlines for a timely #FIH application. Learn more in this Labiotech interview featuring insights from my colleagues, Alejandro Fernandez Martell, Global Principal Scientist and James Berrie, Technical Director, Global Process Development. https://lnkd.in/eFUT5x5Z

Early execution of pre-clinical #toxicology provides confidence to investors, and can be pivotal to securing the next investment round. In standard DNA-to-IND offerings, toxicology animal testing needs to be completed within four to five months, including data analysis and generating a report. Lonza deploys advanced strategies and technologies to meet the deadlines for a timely #FIH application. Learn more in this Labiotech interview featuring insights from my colleagues, Alejandro Fernandez Martell, Global Principal Scientist and James Berrie, Technical Director, Global Process Development. https://lnkd.in/etQJ2PyK

Early execution of pre-clinical #toxicology provides confidence to investors, and can be pivotal to securing the next investment round. In standard DNA-to-IND offerings, toxicology animal testing needs to be completed within four to five months, including data analysis and generating a report. Lonza deploys advanced strategies and technologies to meet the deadlines for a timely #FIH application. Learn more in this Labiotech interview featuring insights from my colleagues, Alejandro Fernandez Martell, Global Principal Scientist and James Berrie, Technical Director, Global Process Development. https://lnkd.in/eatxdGPq

The timely provision of toxicology data to support FIH applications has emerged as the new critical path for increasingly rapid timelines to IND. An earlier execution of pre-clinical toxicology not just ensure meeting the deadlines for FIH, but also provides confidence to investors, and can be pivotal to securing the next investment round. In standard DNA-to-IND offerings, toxicology animal testing needs to be completed within four to five months, including data analysis and generating a report. Lonza deploys advanced strategies and technologies to meet the deadlines for a timely FIH application. Learn more in this Labiotech interview featuring insights from myself and James Berrie, Technical Director, Global Process Development. https://lnkd.in/g3ceW-zm #Biologics #DrugDevelopment #Toxicology #SpeedToClinic

🚀 We are thrilled to launch our new interview series, Minds Behind #VICT3R, where we spotlight the talented individuals shaping the success of the VICT3R project 💡 In our first edition, we’re excited to feature Claus Stie Kallesøe from grit42! Claus shares his background and sheds light on the pivotal role grit42 plays in advancing the project’s mission to reduce the use of animals in toxicology research. ⏩ Swipe through the interview carrousel to discover more about Claus, grit42, and their contributions to VICT3R! #Toxicology #AnimalWelfare #EthicalResearch #AI

The best talents are coming together to reduce animal usage and improve safety evaluations

We are happy to announce that prof. Mathieu Vinken, coordinator of #ONTOX, project has become a partner of the recently launched European #VICT3R project, a transformative collaboration bringing together 33 partner organizations across academia and industry under the European Innovative Health Initiative. VICT3R is pioneering the use of virtual control groups to reduce animal use in toxicology research, marking a significant step forward in ethical and innovative drug and chemical safety evaluation. By leveraging advanced artificial intelligence and statistics and decades of historical data, VICT3R's mission is to replace concurrent control groups with virtual ones, aiming for regulatory acceptance and improved safety assessment methods. VICT3R will not only enhance the ethical standards of research, but will also drive innovation in toxicology and safety evaluation. More information can be found at www.vict3r.eu. #Innovation #Toxicology #AI #ResearchEthics #AnimalWelfare #VICT3R

In this webinar, experts will share sampling techniques, various approaches, and practical tips to reduce animal usage while achieving toxicology study objectives. Register now! https://lnkd.in/ePwQKVh2 #Nonclinical #Preclinical #Toxicology

📊 Industry Insights: Stay Ahead in Nonclinical Development! 📊 Key Trends in Toxicology and Regulatory Science At Plexus Preclinical Services, we’re committed to keeping you informed about the latest trends and advancements in nonclinical development. Understanding these trends can help you navigate challenges and seize opportunities in your projects. 🔍 Key Trends to Watch: Regulatory Changes: Stay updated on evolving regulatory requirements that impact toxicology assessments and submissions. Advancements in Risk Assessment: Innovations in risk assessment methodologies are enhancing the predictability of toxicological outcomes. Focus on Animal Welfare: Increasing emphasis on humane practices in animal research is driving the development of alternative testing methods. Integration of Technology: The use of AI and data analytics is revolutionizing toxicology, leading to more efficient study designs and interpretations. Collaborative Approaches: Greater collaboration between industry, academia, and regulatory bodies is fostering innovation and improving safety standards. 🌟 Why It Matters: Staying informed about these trends enables you to make strategic decisions, ensuring compliance and enhancing the safety and efficacy of your products. 📞 Connect with Us! Want to learn more about how these trends could impact your projects? Reach out to Plexus Preclinical Services for expert insights and tailored consulting! 🌐 Visit: plexuspreclinical.com to know more! 📞 Phone/WhatsApp: +91 9979892613 ✉ Email: info@plexuspreclinical.com. #PlexusPreclinical #IndustryInsights #Toxicology #RegulatoryScience #Pharma #Biotech

Key Trends in Toxicology and Regulatory Science